News
The increasing incidence of genetic and rare diseases is a major factor driving revenue growth in the Antisense ...
2d
Stocktwits on MSNBiogen Shares Slip After $46M Research Charge Hits Quarterly ProfitBiogen shares slipped on Monday after the company said it expects to take a $46 million charge in the second quarter related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results